Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | October 09, 2024 |
| PDB ID | UniProt ID | Title ▲ | Descriptor |
|---|---|---|---|
| 8XSI | 8XSI | SARS-CoV-2 RBD + IMCAS-364 (Local Refinement) | |
| 8XSF | Q9BYF1 | SARS-CoV-2 RBD + IMCAS-364 + hACE2 | |
| 8XSF | P0DTC2 | SARS-CoV-2 RBD + IMCAS-364 + hACE2 | |
| 8XSF | 8XSF | SARS-CoV-2 RBD + IMCAS-364 + hACE2 | |
| 8EL2 | P0DTC2 | SARS-CoV-2 RBD bound to neutralizing antibody Fab ICO-hu23 | |
| 8EL2 | 8EL2 | SARS-CoV-2 RBD bound to neutralizing antibody Fab ICO-hu23 | |
| 7KDG | P0DTC2 | SARS-CoV-2 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS) | Spike glycoprotein |
| 7F3Q | P0DTC2 | SARS-CoV-2 RBD in complex with A5-10 Fab and A34-2 Fab | |
| 7F3Q | 7F3Q | SARS-CoV-2 RBD in complex with A5-10 Fab and A34-2 Fab | |
| 7KLG | P0DTC2 | SARS-CoV-2 RBD in complex with Fab 15033 | |
| 7KLG | 7KLG | SARS-CoV-2 RBD in complex with Fab 15033 | |
| 7KLH | P0DTC2 | SARS-CoV-2 RBD in complex with Fab 15033-7 | |
| 7KLH | 7KLH | SARS-CoV-2 RBD in complex with Fab 15033-7 | |
| 8E1G | P0DTC2 | SARS-CoV-2 RBD in complex with Omicron-neutralizing antibody 2A10 | |
| 8E1G | 8E1G | SARS-CoV-2 RBD in complex with Omicron-neutralizing antibody 2A10 | |
| 7KDH | P0DTC2 | SARS-CoV-2 RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS) | Spike glycoprotein |
| 7BH9 | Q9BYF1 | SARS-CoV-2 RBD-62 in complex with ACE2 peptidase domain | |
| 7BH9 | P0DTC2 | SARS-CoV-2 RBD-62 in complex with ACE2 peptidase domain | |
| 8DCC | P0DTC2 | SARS-CoV-2 Receptor-Binding Domain SPEEDesign Immunogen 3 Bound to P2B-2F6 Fab | |
| 8DCC | 8DCC | SARS-CoV-2 Receptor-Binding Domain SPEEDesign Immunogen 3 Bound to P2B-2F6 Fab | |
| 7N8I | P0DTC2 | SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 (Local Refinement of the NTD/S2L20) | |
| 7N8I | 7N8I | SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 (Local Refinement of the NTD/S2L20) | |
| 7N8H | P0DTC2 | SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 Global Refinement | |
| 7N8H | 7N8H | SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 Global Refinement | |
| 8VYE | 8VYE | SARS-CoV-2 S (C.37 Lambda variant) plus S309, S2L20, and S2X303 Fabs | |
| 8VYE | P0DTC2 | SARS-CoV-2 S (C.37 Lambda variant) plus S309, S2L20, and S2X303 Fabs | |
| 7T67 | P0DTC2 | SARS-CoV-2 S (Spike Glycoprotein) D614G with One(1) RBD Up | |
| 7T3M | P0DTC2 | SARS-CoV-2 S (Spike Glycoprotein) D614G with Three (3) RBDs Up, Bound to Antibody 2-7 scFv, composite map | |
| 7T3M | 7T3M | SARS-CoV-2 S (Spike Glycoprotein) D614G with Three (3) RBDs Up, Bound to Antibody 2-7 scFv, composite map | |
| 7TLY | 7TLY | SARS-CoV-2 S B.1.1.529 Omicron variant (RBD + S309 Local Refinement) | |
| 7TLY | P0DTC2 | SARS-CoV-2 S B.1.1.529 Omicron variant (RBD + S309 Local Refinement) | |
| 7TM0 | P0DTC2 | SARS-CoV-2 S B.1.1.529 Omicron variant + S309 + S2L20 Global Refinement | |
| 7TM0 | 7TM0 | SARS-CoV-2 S B.1.1.529 Omicron variant + S309 + S2L20 Global Refinement | |
| 7SOE | P0DTC2 | SARS-CoV-2 S B.1.617.1 kappa variant + S2X303 Global Refinement | |
| 7SOE | 7SOE | SARS-CoV-2 S B.1.617.1 kappa variant + S2X303 Global Refinement | |
| 7SOB | P0DTC2 | SARS-CoV-2 S B.1.617.1 kappa variant + S309 + S2L20 Global Refinement | |
| 7SOB | 7SOB | SARS-CoV-2 S B.1.617.1 kappa variant + S309 + S2L20 Global Refinement | |
| 7SO9 | P0DTC2 | SARS-CoV-2 S B.1.617.2 delta variant + S2M11 + S2L20 Global Refinement | |
| 7SO9 | 7SO9 | SARS-CoV-2 S B.1.617.2 delta variant + S2M11 + S2L20 Global Refinement | |
| 8VYF | P0DTC2 | SARS-CoV-2 S NTD (C.37 Lambda variant) plus S2L20 and S2X303 Fabs, local refinement | |
| 8VYF | 8VYF | SARS-CoV-2 S NTD (C.37 Lambda variant) plus S2L20 and S2X303 Fabs, local refinement | |
| 7TLZ | 7TLZ | SARS-CoV-2 S NTD B.1.1.529 Omicron variant + S309 Local Refinement | |
| 7TLZ | P0DTC2 | SARS-CoV-2 S NTD B.1.1.529 Omicron variant + S309 Local Refinement | |
| 7SOD | P0DTC2 | SARS-CoV-2 S NTD B.1.617.1 kappa variant S2L20 Local Refinement | |
| 7SOD | 7SOD | SARS-CoV-2 S NTD B.1.617.1 kappa variant S2L20 Local Refinement | |
| 7SOF | P0DTC2 | SARS-CoV-2 S NTD B.1.617.1 kappa variant S2X303 Local Refinement | |
| 7SOF | 7SOF | SARS-CoV-2 S NTD B.1.617.1 kappa variant S2X303 Local Refinement | |
| 7SOA | P0DTC2 | SARS-CoV-2 S NTD B.1.617.2 delta variant + S2L20 Local Refinement | |
| 7SOA | 7SOA | SARS-CoV-2 S NTD B.1.617.2 delta variant + S2L20 Local Refinement | |
| 7QO7 | A0A8A4XEV3 | SARS-CoV-2 S Omicron Spike B.1.1.529 |
